Compare American Water Works Company Inc (AWK) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Water Works Company Inc vs TransMedics Group Inc — how do they compare? American Water Works Company Inc trades at $131.69 (market cap $25.69B), while TransMedics Group Inc trades at $74.59 (market cap $2.62B). The key difference: American Water Works Company Inc is far larger — about 9.8× TransMedics Group Inc's market cap, and American Water Works Company Inc pays a 2.72% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| AWK | TMDX | |
|---|---|---|
Market Cap | $25.69B | $2.62B |
Sector | Utilities | Technology |
52-Week High | $147.00 | $150.42 |
52-Week Low | $121.13 | $61.99 |
Enterprise Value | $41.25B | $3.02B |
Dividend Yield | 2.72% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Water Works Company Inc
American Water Works is the largest investor-owned U.S. water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's only nonregulated business is water services for military bases, which operates under long-term contracts.
Read more on AWK →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
